Outer Membrane Vesicle-Coated Nanoparticle Vaccine Protects Against Acinetobacter baumannii Pneumonia and Sepsis.
暂无分享,去创建一个
Ronnie H. Fang | V. Nizet | Liangfang Zhang | Jiarong Zhou | Elisabet Bjanes | Nishta Krishnan | R. Zurich | N. Menon | Tariq Qayum | Alexandria Hoffman | Elisabet Bjånes
[1] Pallavi Sharma,et al. Immunomodulatory effect of mycobacterial outer membrane vesicles coated nanoparticles , 2022, bioRxiv.
[2] Jiang Ouyang,et al. Emerging vaccine nanotechnology: From defense against infection to sniping cancer , 2022, Acta Pharmaceutica Sinica B.
[3] M. Šantak,et al. Current view on novel vaccine technologies to combat human infectious diseases , 2021, Applied microbiology and biotechnology.
[4] M. Zhang,et al. Regulation of the formation and structure of biofilms by quorum sensing signal molecules packaged in outer membrane vesicles. , 2021, The Science of the total environment.
[5] Ronnie H. Fang,et al. Physical Disruption of Solid Tumors by Immunostimulatory Microrobots Enhances Antitumor Immunity , 2021, Advanced materials.
[6] V. Nizet,et al. Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus , 2021, Microorganisms.
[7] B. Stanton. Extracellular Vesicles and Host–Pathogen Interactions: A Review of Inter-Kingdom Signaling by Small Noncoding RNA , 2021, Genes.
[8] S. McClean,et al. Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It , 2021, Vaccines.
[9] I. Ferlenghi,et al. Stability of Outer Membrane Vesicles-Based Vaccines, Identifying the Most Appropriate Methods to Detect Changes in Vaccine Potency , 2021, Vaccines.
[10] Crystal Ma,et al. Where are we and how far is there to go in the development of an Acinetobacter vaccine? , 2021, Expert review of vaccines.
[11] C. MacLennan,et al. Outer membrane vesicle vaccines. , 2020, Seminars in immunology.
[12] G. Innes,et al. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions — New Jersey, February–July 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[13] Patrick S. Gellings,et al. Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine , 2020, Pathogens.
[14] Jiru Xu,et al. Risk factors and outcomes of bloodstream infections caused by Acinetobacter baumannii: a case-control study. , 2020, Diagnostic microbiology and infectious disease.
[15] Hang Zhao,et al. Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities , 2020, Frontiers in Bioengineering and Biotechnology.
[16] F. Mancini,et al. Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans , 2020, Human vaccines & immunotherapeutics.
[17] R. Rappuoli,et al. Vaccines Against Antimicrobial Resistance , 2020, Frontiers in Immunology.
[18] P. Hsueh,et al. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? , 2020, Journal of Microbiology, Immunology and Infection.
[19] T. Ren,et al. Nanoparticle reinforced bacterial outer-membrane vesicles effectively prevent fatal infection of carbapenem-resistant Klebsiella pneumonia. , 2019, Nanomedicine : nanotechnology, biology, and medicine.
[20] M. McConnell,et al. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection. , 2019, Vaccine.
[21] S. Liew,et al. The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis. , 2019, The Journal of infection.
[22] R. Bonomo,et al. Human pleural fluid triggers global changes in the transcriptional landscape of Acinetobacter baumannii as an adaptive response to stress , 2019, Scientific Reports.
[23] Antibiotic resistance threats in the United States, 2019 , 2019 .
[24] M. Hamidian,et al. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii , 2019, Microbial genomics.
[25] A. Peleg,et al. The Mechanisms of Disease Caused by Acinetobacter baumannii , 2019, Front. Microbiol..
[26] Ronnie H. Fang,et al. Biomimetic Nanotechnology toward Personalized Vaccines , 2019, Advanced materials.
[27] Wangxue Chen,et al. Acute intraperitoneal infection with a hypervirulent Acinetobacter baumannii isolate in mice , 2019, Scientific Reports.
[28] R. Carlisle,et al. Novel approaches for the design, delivery and administration of vaccine technologies , 2019, Clinical and experimental immunology.
[29] J. Rello,et al. Ventilator-Associated Pneumonia due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality , 2019, Medicina.
[30] U. Baxa,et al. Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses , 2018, Nature Immunology.
[31] Maxim Shevtsov,et al. Nanoparticle Vaccines Against Infectious Diseases , 2018, Front. Immunol..
[32] B. Velimirov,et al. Unexpected aspects in the dynamics of horizontal gene transfer of prokaryotes: the impact of outer membrane vesicles , 2018, Wiener Medizinische Wochenschrift.
[33] K. Jansen,et al. The role of vaccines in fighting antimicrobial resistance (AMR) , 2018, Human vaccines & immunotherapeutics.
[34] Ronnie H. Fang,et al. Cell Membrane Coating Nanotechnology , 2018, Advanced materials.
[35] D. Martens,et al. Bioengineering bacterial outer membrane vesicles as vaccine platform. , 2017, Biotechnology advances.
[36] A. Jan. Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update , 2017, Front. Microbiol..
[37] Ronnie H. Fang,et al. Cell membrane-derived nanomaterials for biomedical applications. , 2017, Biomaterials.
[38] Ziwen Zhao,et al. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality , 2017, BMC Infectious Diseases.
[39] K. Peters,et al. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii , 2016, Proceedings of the National Academy of Sciences.
[40] M. Kuehn,et al. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions , 2015, Nature Reviews Microbiology.
[41] M. Stork,et al. Outer membrane vesicles as platform vaccine technology , 2015, Biotechnology journal.
[42] M. Roessle,et al. Fusion of Legionella pneumophila outer membrane vesicles with eukaryotic membrane systems is a mechanism to deliver pathogen factors to host cell membranes , 2015, Cellular microbiology.
[43] C. Bumroongkit,et al. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia , 2015, Journal of Intensive Care.
[44] Je Chul Lee,et al. Acinetobacter baumannii Outer Membrane Vesicles Elicit a Potent Innate Immune Response via Membrane Proteins , 2013, PloS one.
[45] Ronnie H. Fang,et al. Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes , 2013, Advanced materials.
[46] A. Gorringe,et al. Bexsero: a multicomponent vaccine for prevention of meningococcal disease. , 2012, Human vaccines & immunotherapeutics.
[47] M. Adams,et al. Active and Passive Immunization Protects against Lethal, Extreme Drug Resistant-Acinetobacter baumannii Infection , 2012, PloS one.
[48] Je Chul Lee,et al. Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles , 2011, PloS one.
[49] K. Yamaguchi,et al. A New Method for the Evaluation of Vaccine Safety Based on Comprehensive Gene Expression Analysis , 2010, Journal of biomedicine & biotechnology.
[50] Priyabrata Mukherjee,et al. Gold nanoparticles: opportunities and challenges in nanomedicine , 2010, Expert opinion on drug delivery.
[51] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[52] Catherine J. Murphy,et al. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? , 2010, Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology.
[53] J. Cavaillon,et al. Resilience to bacterial infection: difference between species could be due to proteins in serum. , 2010, The Journal of infectious diseases.
[54] Y. Gho,et al. Proteome analysis of outer membrane vesicles from a clinical Acinetobacter baumannii isolate. , 2009, FEMS microbiology letters.
[55] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[56] Vasso Apostolopoulos,et al. Pathogen recognition and development of particulate vaccines: does size matter? , 2006, Methods.
[57] Jie Li,et al. Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors1 , 2004, The Journal of Immunology.
[58] J. Garnacho-Montero,et al. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[59] B. Zomer,et al. Meningitis bacterium is viable without endotoxin , 1998, Nature.
[60] P. Buchy,et al. Impact of vaccines on antimicrobial resistance. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[61] C. Esimone,et al. An assessment, in mice, of the safety of the childhood immunization vaccines sourced from three south-eastern states of Nigeria , 2016 .
[62] Ronnie H. Fang,et al. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. , 2015, Nano letters.
[63] Chun-Xia Zhao,et al. Nanoparticle vaccines. , 2014, Vaccine.
[64] K. Kanik,et al. Prospective study of antibacterial susceptibility, risk factors and outcome of 157 episodes of Acinetobacter baumannii bacteremia in 1999 in Slovakia. , 2001, Scandinavian journal of infectious diseases.